Home - Xtalks

Xtalks — The Life Science Community™

Xtalks connects industry professionals to share the latest in pharma, biotech, medtech, healthcare and research.

Join free for webinars, articles, videos, job postings and more.

Xtalks — The Life Science Community™

Xtalks connects industry professionals to share the latest in pharma, biotech, medtech, healthcare and research.

Join free for webinars, articles, videos, job postings and more.

Upcoming Webinars

View All

June 16, 2026

Post‑ASCO 2026: Translating Insights into Trial Development and Execution Strategies

June 17, 2026

Prevent Advanced Therapy Program Delays with Early Supply Chain Strategy

June 18, 2026

Reduce Supply Chain Delays in Life Sciences Manufacturing

June 18, 2026

Hybrid Operating Models: A Practical Guide to Harmonizing Priorities in Clinical Development

June 18, 2026

Strengthen Participant-Site Readiness for Complex Rare Disease Trials

June 22, 2026

Empowering Clinical Sites to Drive Engagement and Retention among Human-Centered Trials

June 22, 2026

Why Level Setting around Site Technology May Be The Most Overlooked Step in Clinical Trial Planning

June 22, 2026

Connect Commercial Models to Improve Decision-Making in the Pharma AI Era

June 16, 2026

Post‑ASCO 2026: Translating Insights into Trial Development and Execution Strategies

June 17, 2026

Prevent Advanced Therapy Program Delays with Early Supply Chain Strategy

June 18, 2026

Reduce Supply Chain Delays in Life Sciences Manufacturing

June 18, 2026

Hybrid Operating Models: A Practical Guide to Harmonizing Priorities in Clinical Development

June 18, 2026

Strengthen Participant-Site Readiness for Complex Rare Disease Trials

June 22, 2026

Empowering Clinical Sites to Drive Engagement and Retention among Human-Centered Trials

June 22, 2026

Why Level Setting around Site Technology May Be The Most Overlooked Step in Clinical Trial Planning

June 22, 2026

Connect Commercial Models to Improve Decision-Making in the Pharma AI Era

On-Demand Webinars

View All

June 15, 2026

AI-driven Rapid Response In Supply Chains With Lower Cost To Serve

June 15, 2026

Plan Patient Interviews to Strengthen Trial Data Readiness

June 12, 2026

Executing MRD in Oncology Trials: From Protocol Design to Commercial Impact

June 12, 2026

Avoid Post-FACS Sorting Delays: Choosing the Best Single B Cell Workflow for Antibody Discovery (Broadcast 2)

June 15, 2026

AI-driven Rapid Response In Supply Chains With Lower Cost To Serve

June 15, 2026

Plan Patient Interviews to Strengthen Trial Data Readiness

June 12, 2026

Executing MRD in Oncology Trials: From Protocol Design to Commercial Impact

June 12, 2026

Avoid Post-FACS Sorting Delays: Choosing the Best Single B Cell Workflow for Antibody Discovery (Broadcast 2)

Featured Editorial

Vitals

Your source for industry focused blog articles, news, videos, polls & quizzes

View All

Hemab Therapeutics IPO Raises $346.7M for Bleeding Disorder Pipeline

Hemab is studying subcutaneous, or under-the-skin, treatments for rare bleeding disorders.

News June 15, 2026

Seaport Therapeutics IPO Raises $260M for Neuropsychiatry Pipeline

News June 15, 2026

Ebglyss (Lebrikizumab) Approval Adds 8-Week Maintenance Option for Eczema

News June 12, 2026

Hemab Therapeutics IPO Raises $346.7M for Bleeding Disorder Pipeline

News June 15, 2026

Seaport Therapeutics IPO Raises $260M for Neuropsychiatry Pipeline

News June 15, 2026

Ebglyss (Lebrikizumab) Approval Adds 8-Week Maintenance Option for Eczema

News June 12, 2026

Vitals

Your source for industry focused blog articles, news, videos, polls & quizzes

View All